Every round on record, with the sources behind each and the investors on them.
A fungal protein (mycoprotein) developer
maashcompany.comLinkedInBrussels, BelgiumAgtech and foodFounded 2021
2 sources · checked 1 time, last 16d ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The €12.15 million package combines the €5.85 million equity raise with €4.3 million in public support and a €2 million Bpifrance loan; the amount field therefore uses the equity portion.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $6.7M €5.85 million | 2026-08-25 | not stated | No recent discussion |
2 sources · checked 1 time, last 16d ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources
The €12.15 million package combines the €5.85 million equity raise with €4.3 million in public support and a €2 million Bpifrance loan; the amount field therefore uses the equity portion. | ||||
MAASH makes LoCylia, a fungi-based protein ingredient produced by fermentation for food formulators and other B2B partners.
Checked against 9 sources on Sep 24
Also named as backers in company research: Première Usine programme, France 2030